Mortality benefit of vasopressor and inotropic agents in septic shock: A Bayesian network meta-analysis of randomized controlled trials

Journal of Critical Care

Volumn 29, Issue 5, 2014, Pages 706-710

  Oba, Yuji ^a   Lone, Nazir A ^a  

^a University of Missouri   (United States)

Author keywords

Adrenergic agonists; Shock septic; Vasoconstrictor agents

Indexed keywords

DOBUTAMINE; DOPAMINE; DOPEXAMINE; NORADRENALIN; VASOPRESSIN; ADRENALIN; ARGIPRESSIN; CARDIOTONIC AGENT; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE; HYPERTENSIVE FACTOR; INOTROPIC AGENT;

ARTICLE; BAYES THEOREM; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG UTILIZATION; EVIDENCE BASED MEDICINE; HUMAN; LOW DRUG DOSE; META ANALYSIS; MONOTHERAPY; MORTALITY; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SEPTIC SHOCK; SYSTEMATIC REVIEW; ANALOGS AND DERIVATIVES; SHOCK, SEPTIC; DOSE RESPONSE; DRUG CHOICE; OUTCOME ASSESSMENT; SURVIVAL TIME;

ARGININE VASOPRESSIN; BAYES THEOREM; CARDIOTONIC AGENTS; DOBUTAMINE; DOPAMINE; EPINEPHRINE; HUMANS; NOREPINEPHRINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 84906055494     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.04.011     Document Type: Article

References (31)

1. Angus D.C., van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013, 369(9):840-851.
2. Annane D., Bellissant E., Cavaillon J.M. Septic shock. Lancet 2005, 365(9453):63-78.
3. Sakr Y., Reinhart K., Vincent J.L., et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study. Crit Care Med 2006, 34(3):589-597.
4. Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41(2):580-637.
5. Havel C., Arrich J., Losert H., et al. Vasopressors for hypotensive shock. Cochrane Database Syst Rev 2011, (5):CD003709.
6. Vasu T.S., Cavallazzi R., Hirani A., et al. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials. J Intensive Care Med 2012, 27(3):172-178.
7. Annane D., Vignon P., Renault A., et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007, 370(9588):676-684.
8. Lu G., Ades A.E. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004, 23(20):3105-3124.
9. Jansen J.P., Crawford B., Bergman G., et al. Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health 2008, 11(5):956-964.
10. Toft N., Innocent G.T., Gettinby G., et al. Assessing the convergence of Markov Chain Monte Carlo methods: an example from evaluation of diagnostic tests in absence of a gold standard. Prev Vet Med 2007, 79(2-4):244-256.
11. Spiegelhalter D.J., Best N.G., Carlin B.P., et al. Bayesian measures of model complexity and fit. J R Stat Soc Series B 2002, (64):583-639.
12. Bucher H.C., Guyatt G.H., Griffith L.E., et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997, 50(6):683-691.
13. Baker W.L., White C.M., Cappelleri J.C., et al. Understanding heterogeneity in meta-analysis: the role of meta-regression. Int J Clin Pract 2009, 63(10):1426-1434.
14. Ruokonen E., Takala J., Kari A., et al. Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993, 21(9):1296-1303.
15. Martin C., Papazian L., Perrin G., et al. Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?. Chest 1993, 103(6):1826-1831.
16. Marik P.E., Mohedin M. The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994, 272(17):1354-1357.
17. Mathur S.M., Dhunna R., Chakraborty A. Comparison of dopamine and norepinephrine in the management of septic shock using impedance cardiography. Indian J Crit Care Med 2007, 11(4):186-191.
18. Patel G.P., Grahe J.S., Sperry M., et al. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock. Shock 2010, 33(4):375-380.
19. De Backer D., Biston P., Devriendt J., et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010, 362(9):779-789.
20. Myburgh J.A., Higgins A., Jovanovska A., et al. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 2008, 34(12):2226-2234.
21. Russell J.A., Walley K.R., Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358(9):877-887.
22. Lauzier F., Levy B., Lamarre P., et al. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med 2006, 32(11):1782-1789.
23. Levy B., Bollaert P.E., Charpentier C., et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study. Intensive Care Med 1997, 23(3):282-287.
24. Seguin P., Bellissant E., Le Tulzo Y., et al. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 2002, 71(5):381-388.
25. Schmoelz M., Schelling G., Dunker M., et al. Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock. J Cardiothorac Vasc Anesth 2006, 20(2):173-178.
26. Seguin P., Laviolle B., Guinet P., et al. Dopexamine and norepinephrine versus epinephrine on gastric perfusion in patients with septic shock: a randomized study (NCT00134212). Crit Care 2006, 10(1):R32.
27. De Backer D., Aldecoa C., Njimi H., et al. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 2012, 40(3):725-730.
28. De Backer D., Creteur J., Silva E., et al. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?. Crit Care Med 2003, 31(6):1659-1667.
29. Morelli A., Ertmer C., Rehberg S., et al. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. Crit Care 2008, 12(6):R143.
30. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345(19):1368-1377.
31. The ProCESS Investigators A Randomized Trial of Protocol-Based Care for Early Septic Shock. N Engl J Med 2014, 370(18):1683-1693.